Do you use Facebook to look for health information? If you said "yes," and use social networking sites to research your health, you could be in the minority, or majority, depending on which study you read. Recently, a survey released by the ...

Read more...

With little notice, UnitedHealth released a major paper recently considering diabetes in America. First the bad news: a large portion of our population either has the disease or is pre-diabetic. Now, the really bad news: diabetes and pre-diabetes rates are going to soar in the coming decade, according to the analysis, in part driven by the obesity crisis. I’ll return back to the study in a moment, but it underscores a ...

Read more...

My mom doesn’t take any diabetes medicine.  She keeps her blood sugars normal through a combination of common sense and careful carbohydrate consumption. A few months ago, she had to be hospitalized for what she calls a “minor procedure.”  The procedure went fine, but not the food.  The first meal they brought her consisted of breaded fish (frozen), mashed potatoes (instant), corn (canned), a dinner roll (frozen), and tea (2 sugar ...

Read more...

The Dartmouth Atlas of Health is once again throwing a harsh spotlight on McAllen, Texas. This time the Mexican border town has the highest rate of leg amputations in the nation, a new report released recently showed. McAllen's rate was ten times the rate of Provo, Utah, which had the lowest rate of leg amputations among the Medicare eligible population. The national average was one-third of McAllen's rate. McAllen became ...

Read more...

Most of the illnesses that occur today are chronic like diabetes, heart disease, cancer or kidney disease. These stay with us for the rest of our lives, are debilitating, and are expensive to treat. But in many cases they are not all that difficult to prevent. Unfortunately, our dietary guidelines are of little or no help in this regard but could be. In 1941, following studies that demonstrated ...

Read more...

Though I am not going to say that the New York Times lied, they either purposely and grossly misrepresented the truth or did a horrible job of reporting. In their article, "Diabetes Drug Maker Hid Test Data, Files Indicate" the Times states that Avandia maker GSK "secretly began" a study which "provided clear signs that it (Avandia) was riskier to the heart." In fact, the study in question, called study ...

Read more...

Responses to the Avandia panel have been all over the map, as cleverly noted on the Wall Street Journal's Health Blog. Avandia is “dead” (Forbes), or, perhaps worse, “now a Zombie” (BNET). By contrast, others thought the panel granted Avandia a “reprieve” (Wall Street Journal and that Avandia would now probably be allowed to stay on the market (Los Angeles Times, Pharmalot). All these views are ...

Read more...

I have a lot of diabetes patients and have been an avid user of the thiazolidinediones (TZD) class. There are many reasons to like the TZD's:

  • The older, generic medicines like metformin and sulfonylureas are known to fail over time. After 3 years, most patients on one of these drugs lose control of their blood sugar. In contrast, patients on TZD's maintain glycemic control (at least up to 4-5 years which ...

    Read more...

by Kristina Fiore More than one in 10 heart disease deaths may be attributable to diabetes, researchers say. In a meta-analysis of more than 100 studies, diabetes was associated with a twofold increased risk of the disease and was estimated to be accountable for 11% of vascular deaths, according to Nadeem Sarwar, MD, of the University of Cambridge in England, and colleagues. They reported their findings online in The Lancet and will present ...

Read more...

by Emily P. Walker An advisory panel voted 20-12 to recommend that the FDA allow rosiglitazone (Avandia) to stay on the market, but most panelists want to see the controversial diabetes drug carry tougher warnings on its label. Wednesday's vote marks the second time an FDA advisory panel has essentially endorsed rosiglitazone. In 2007, a panel voted that while the drug appears to carry a ...

Read more...